Clinical trials
Phase 1 Neuroblastoma trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 3 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| GlaxoSmithKline | 2 |
| AbbVie | 1 |
| Bayer | 1 |
| Cancer Research UK | 1 |
| Eli Lilly and Company | 1 |
| New Approaches to Neuroblastoma Therapy Consortium | 1 |
| Orphelia Pharma | 1 |
| University College, London | 1 |
| University Hospital Southampton NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroblastoma | 13 |
| Neoplasms | 6 |
| Recurrence | 3 |
| Rhabdomyosarcoma | 3 |
| Carcinoma | 1 |
| Cytokine Release Syndrome | 1 |
| Epilepsy | 1 |
| Glioma | 1 |
| Granuloma, Plasma Cell | 1 |
| Hepatoblastoma | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.